MEHRA UNEEK (Chief Financial Officer) received a stock award from BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/12/2026ACC: 0001193125-26-104384
Officer· Chief Financial Officer
Since Mar 2026
+128.33K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
128.33K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+23.33K
Price / share
—
Trade value
—
% of position
New position
3/10/2026
0.00→23.33K
Total
Net shares
+23.33K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/10/2026 | A · Award | +23.33K | — | — | New position | 0.00 | 23.33K |
| Total | +23.33K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
105K shares
Shares
+105K
Strike price
10.19
Held after
105K
Exercisable
—
3/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock105K shares | 3/10/2026 | A · Award | +105K | 10.19 | — | 105K |